264 related articles for article (PubMed ID: 26380930)
1. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.
Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR
Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930
[TBL] [Abstract][Full Text] [Related]
2. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.
Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL
Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557
[TBL] [Abstract][Full Text] [Related]
3. Synthetic modifications of the immunomodulating peptide thymopentin to confer anti-mycobacterial activity.
Wang Y; Ke XY; Khara JS; Bahety P; Liu S; Seow SV; Yang YY; Ee PL
Biomaterials; 2014 Mar; 35(9):3102-9. PubMed ID: 24411680
[TBL] [Abstract][Full Text] [Related]
4. Amphipathic alpha helical antimicrobial peptides.
Giangaspero A; Sandri L; Tossi A
Eur J Biochem; 2001 Nov; 268(21):5589-600. PubMed ID: 11683882
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.
Wiradharma N; Khoe U; Hauser CA; Seow SV; Zhang S; Yang YY
Biomaterials; 2011 Mar; 32(8):2204-12. PubMed ID: 21168911
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity.
Zhu X; Zhang L; Wang J; Ma Z; Xu W; Li J; Shan A
Acta Biomater; 2015 May; 18():155-67. PubMed ID: 25735802
[TBL] [Abstract][Full Text] [Related]
7. Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability.
Khara JS; Priestman M; Uhía I; Hamilton MS; Krishnan N; Wang Y; Yang YY; Langford PR; Newton SM; Robertson BD; Ee PL
J Antimicrob Chemother; 2016 Aug; 71(8):2181-91. PubMed ID: 27118774
[TBL] [Abstract][Full Text] [Related]
8. Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions.
Zelezetsky I; Pag U; Sahl HG; Tossi A
Peptides; 2005 Dec; 26(12):2368-76. PubMed ID: 15939509
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.
Rodríguez A; Villegas E; Montoya-Rosales A; Rivas-Santiago B; Corzo G
PLoS One; 2014; 9(7):e101742. PubMed ID: 25019413
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane segment peptides with double D-amino acid replacements: helicity, hydrophobicity, and antimicrobial activity.
Maeda M; Melnyk RA; Partridge AW; Liu LP; Deber CM
Biopolymers; 2003; 71(1):77-84. PubMed ID: 12712502
[TBL] [Abstract][Full Text] [Related]
11. Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria.
Jena P; Mishra B; Leippe M; Hasilik A; Griffiths G; Sonawane A
Peptides; 2011 May; 32(5):881-7. PubMed ID: 21396418
[TBL] [Abstract][Full Text] [Related]
12. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
[TBL] [Abstract][Full Text] [Related]
13. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.
Chen Y; Guarnieri MT; Vasil AI; Vasil ML; Mant CT; Hodges RS
Antimicrob Agents Chemother; 2007 Apr; 51(4):1398-406. PubMed ID: 17158938
[TBL] [Abstract][Full Text] [Related]
14. Role of helicity on the anticancer mechanism of action of cationic-helical peptides.
Huang YB; He LY; Jiang HY; Chen YX
Int J Mol Sci; 2012; 13(6):6849-6862. PubMed ID: 22837667
[TBL] [Abstract][Full Text] [Related]
15. Role of helicity of α-helical antimicrobial peptides to improve specificity.
Huang Y; He L; Li G; Zhai N; Jiang H; Chen Y
Protein Cell; 2014; 5(8):631-42. PubMed ID: 24805306
[TBL] [Abstract][Full Text] [Related]
16. Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of α-Helical Membrane-Active Peptides.
Sun S; Zhao G; Huang Y; Cai M; Yan Q; Wang H; Chen Y
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280948
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
[TBL] [Abstract][Full Text] [Related]
18. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
[TBL] [Abstract][Full Text] [Related]
19. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
[TBL] [Abstract][Full Text] [Related]
20. RV-23, a Melittin-Related Peptide with Cell-Selective Antibacterial Activity and High Hemocompatibility.
Zhang SK; Ma Q; Li SB; Gao HW; Tan YX; Gong F; Ji SP
J Microbiol Biotechnol; 2016 Jun; 26(6):1046-56. PubMed ID: 26975766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
